Free Trial
NASDAQ:NBTX

Nanobiotix (NBTX) Stock Price, News & Analysis

Nanobiotix logo
$3.79 -0.04 (-1.04%)
(As of 11/22/2024 ET)

About Nanobiotix Stock (NASDAQ:NBTX)

Key Stats

Today's Range
$3.60
$3.91
50-Day Range
$3.70
$5.75
52-Week Range
$3.57
$8.96
Volume
6,171 shs
Average Volume
8,463 shs
Market Capitalization
$178.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.50
Consensus Rating
Buy

Company Overview

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.

Nanobiotix Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
40th Percentile Overall Score

NBTX MarketRank™: 

Nanobiotix scored higher than 40% of companies evaluated by MarketBeat, and ranked 703rd out of 956 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nanobiotix has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nanobiotix has only been the subject of 1 research reports in the past 90 days.

  • Read more about Nanobiotix's stock forecast and price target.
  • Earnings Growth

    Earnings for Nanobiotix are expected to grow in the coming year, from ($1.18) to ($0.86) per share.

  • Percentage of Shares Shorted

    0.07% of the outstanding shares of Nanobiotix have been sold short.
  • Short Interest Ratio / Days to Cover

    Nanobiotix has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nanobiotix has recently increased by 10.46%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nanobiotix does not currently pay a dividend.

  • Dividend Growth

    Nanobiotix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.07% of the outstanding shares of Nanobiotix have been sold short.
  • Short Interest Ratio / Days to Cover

    Nanobiotix has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nanobiotix has recently increased by 10.46%, indicating that investor sentiment is decreasing significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Nanobiotix insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 3.45% of the stock of Nanobiotix is held by insiders.

    • Percentage Held by Institutions

      Only 38.81% of the stock of Nanobiotix is held by institutions.

    • Read more about Nanobiotix's insider trading history.
    Receive NBTX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter.

    NBTX Stock News Headlines

    Nanobiotix’s Market Influence and Innovation Unveiled
    “This Changes Everything” - Trump Hands Millions Massive IRS Gift
    Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…
    Nanobiotix Strengthens Growth and Financial Prospects
    Nanobiotix S.A. ADR
    See More Headlines

    NBTX Stock Analysis - Frequently Asked Questions

    Nanobiotix's stock was trading at $7.28 on January 1st, 2024. Since then, NBTX stock has decreased by 48.0% and is now trading at $3.7884.
    View the best growth stocks for 2024 here
    .

    Nanobiotix (NBTX) raised $95 million in an initial public offering on Friday, December 11th 2020. The company issued 6,500,000 shares at a price of $14.69 per share. Jefferies, Evercore ISI, UBS Investment Bank and Gilbert DuPont acted as the underwriters for the IPO.

    Shares of NBTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
    Compare Top Brokerages Here.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Nanobiotix investors own include PayPal (PYPL), Sirius XM (SIRI), Ardelyx (ARDX), BridgeBio Pharma (BBIO), Cogent Communications (CCOI), Citius Pharmaceuticals (CTXR) and Datadog (DDOG).

    Company Calendar

    Today
    11/23/2024
    Fiscal Year End
    12/31/2024

    Industry, Sector and Symbol

    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:NBTX
    Fax
    N/A
    Employees
    100
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $11.50
    High Stock Price Target
    $12.00
    Low Stock Price Target
    $11.00
    Potential Upside/Downside
    +203.6%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    4 Analysts

    Profitability

    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    $36.22 million
    Book Value
    ($0.04) per share

    Miscellaneous

    Free Float
    45,507,000
    Market Cap
    $178.56 million
    Optionable
    Not Optionable
    Beta
    0.33
    Ten Starter Stocks For Beginners to Buy Now Cover

    Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

    Get This Free Report

    This page (NASDAQ:NBTX) was last updated on 11/24/2024 by MarketBeat.com Staff
    From Our Partners